LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Beneficial effects of angiotensin-(1-7) against deoxycorticosterone acetate-induced diastolic dysfunction occur independently of changes in blood pressure.

de Almeida, Pedro W Machado / Melo, Marcos Barrouin / Lima, Ricardo de Freitas / Gavioli, Mariana / Santiago, Nivia M / Greco, Leonardo / Jesus, Itamar C G / Nocchi, Eduardo / Parreira, Amanda / Alves, Marcia N M / Mitraud, Luciana / Resende, Rodrigo Ribeiro / Campagnole-Santos, Maria José / Dos Santos, Robson Augusto Souza / Guatimosim, Silvia

Hypertension (Dallas, Tex. : 1979)

2015  Volume 66, Issue 2, Page(s) 389–395

Abstract: ... signaling against DOCA-induced diastolic dysfunction occurs independently of BP attenuation and is mediated ... heart failure. On the contrary, angiotensin (Ang)-(1-7) has emerged as a potential strategy for treatment of cardiac dysfunction ... of Ang-(1-7) in hypertensive models is its dependence on blood pressure (BP) reduction. Here ...

Abstract Mineralocorticoids have been implicated in the pathogenesis of diastolic heart failure. On the contrary, angiotensin (Ang)-(1-7) has emerged as a potential strategy for treatment of cardiac dysfunction induced by excessive mineralocorticoid receptor activation. A critical question about the cardioprotective effect of Ang-(1-7) in hypertensive models is its dependence on blood pressure (BP) reduction. Here, we addressed this question by investigating the mechanisms involved in Ang-(1-7) cardioprotection against mineralocorticoid receptor activation. Sprague-Dawley (SD) and transgenic (TG) rats that overexpress an Ang-(1-7) producing fusion protein (TG(A1-7)3292) were treated with deoxycorticosterone acetate (DOCA) for 6 weeks. After treatment, SD rats became hypertensive and developed ventricular hypertrophy. These parameters were attenuated in TG-DOCA. SD-DOCA rats developed diastolic dysfunction which was associated at the cellular level with reduced Ca(2+) transient. Oppositely, TG-DOCA myocytes presented enhanced Ca(2+) transient. Moreover, higher extracellular signal-regulated kinase phosphorylation, type 1 phosphatase, and protein kinase Cα levels were found in SD-DOCA cells. In vivo, pressor effects of DOCA can contribute to the diastolic dysfunction, raising the question of whether protection in TG was a consequence of reduced BP. To address this issue, BP in SD-DOCA was kept at TG-DOCA level by giving hydralazine or by reducing the DOCA amount given to rats (Low-DOCA). Under similar BP, diastolic dysfunction and molecular changes were still evident in DOCA-hydralazine and SD-low-DOCA, but not in TG-DOCA. In conclusion, Ang-(1-7) protective signaling against DOCA-induced diastolic dysfunction occurs independently of BP attenuation and is mediated by the activation of pathways involved in Ca(2+) handling, hypertrophy, and survival.
MeSH term(s) Angiotensin I/pharmacology ; Angiotensin I/therapeutic use ; Animals ; Blood Pressure/drug effects ; Blood Pressure/physiology ; Calcium/physiology ; Calcium Signaling/drug effects ; Calcium Signaling/physiology ; Desoxycorticosterone Acetate/adverse effects ; Disease Models, Animal ; Dose-Response Relationship, Drug ; Heart Failure, Diastolic/chemically induced ; Heart Failure, Diastolic/physiopathology ; Heart Failure, Diastolic/prevention & control ; Hydralazine/pharmacology ; Hypertension/physiopathology ; Male ; Peptide Fragments/pharmacology ; Peptide Fragments/therapeutic use ; Rats ; Rats, Sprague-Dawley ; Rats, Transgenic
Chemical Substances Peptide Fragments ; Hydralazine (26NAK24LS8) ; Desoxycorticosterone Acetate (6E0A168OB8) ; Angiotensin I (9041-90-1) ; angiotensin I (1-7) (IJ3FUK8MOF) ; Calcium (SY7Q814VUP)
Language English
Publishing date 2015-08
Publishing country United States
Document type Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID 423736-5
ISSN 1524-4563 ; 0194-911X ; 0362-4323
ISSN (online) 1524-4563
ISSN 0194-911X ; 0362-4323
DOI 10.1161/HYPERTENSIONAHA.114.04893
Shelf mark
Zs.A 1488: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top